NDAINJECTIONINJECTABLEPriority Review
Approved
Jul 1950
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
LEVOPHED (norepinephrine bitartrate) by Pfizer is (alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action). First approved in 1950.
Drug data last refreshed 21h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LEVOPHED (norepinephrine bitartrate) is a classic sympathomimetic amine administered by IV injection that combines alpha-adrenergic vasoconstriction with beta-adrenergic inotropic and coronary vasodilatory effects. It is indicated for acute hypotensive states and cardiogenic shock where blood pressure support and cardiac output restoration are critical. The drug works by stimulating alpha and beta adrenergic receptors to increase peripheral vascular resistance, heart rate, and myocardial contractility.
LOE Approaching
As LOE approaches, the brand team is likely stabilizing or consolidating operations with focus on defensive positioning and cost management rather than growth initiatives.
Mechanism of Action
(alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LEVOPHED offers stability and deep institutional expertise in critical care delivery, but limited growth trajectory and career acceleration opportunities given the product's mature, generic-competitive lifecycle stage. This is a career fit for professionals seeking steady market presence and clinical credibility rather than high-impact commercial scaling or launch experience.
Hospital Account ManagerCritical Care Specialist
Worked on LEVOPHED at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.